Harvest Fund Management’s Guardant Health GH Stock Holding History

Harvest Fund Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$34K	Sell	364 -1,500	-80%	-$151K	﹤0.01%	370
2025 Q4	$190K	Hold	1,864	–	–	0.01%	349
2025 Q3	$117K	Buy	+1,864	New	+$101K	0.01%	376
2024 Q3	–	Sell	-3,331	Closed	-$96K	–	658
2024 Q2	$96K	Buy	+3,331	New	+$77.6K	0.01%	415
2023 Q4	–	Sell	-140	Closed	-$4K	–	660
2023 Q3	$4K	Sell	140 -102	-42%	-$3.59K	﹤0.01%	577
2023 Q2	$9K	Buy	+242	New	+$6.95K	﹤0.01%	563
2021 Q2	–	Sell	-98	Closed	-$14K	–	798
2021 Q1	$14K	Buy	+98	New	+$14.8K	﹤0.01%	702
2020 Q1	–	Sell	-651	Closed	-$52K	–	435
2019 Q4	$52K	Buy	+651	New	+$46.9K	0.01%	282

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harvest Fund Management's GH Position: Q1 2026 in Review

Harvest Fund Management reduced its Guardant Health (GH) stake by 80% in Q1 2026, selling an estimated $151K and leaving 364 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #370.

Harvest Fund Management first reported a position in GH in Q4 2019 and has held it in 8 quarters since. The position peaked at $190K in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

Harvest Fund Management held 364 shares of Guardant Health worth $34K as of Q1 2026.
Harvest Fund Management sold 1,500 Guardant Health shares in Q1 2026, an estimated $151K.
Guardant Health made up ﹤0.01% of Harvest Fund Management's portfolio in Q1 2026, its #370 holding.
Harvest Fund Management first reported a position in Guardant Health in Q4 2019 and has held it in 8 quarters since.
Harvest Fund Management's Guardant Health position peaked at $190K in Q4 2025.
481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Harvest Fund Management's 13F filing for Q1 2026, filed 14 May 2026.